Chronic Fatigue Protocol

An integrative, PEM-informed approach for adults living with chronic fatigue, post-viral fatigue syndromes, or overlap conditions — a serious, biologically real, often-invalidated illness.

At a Glance

What it targets: The underlying biology of chronic fatigue — mitochondrial dysfunction, nutritional depletion, oxidative stress, sleep disturbance, immune and gut imbalance — within a pacing-first framework that respects post-exertional malaise.

Who it’s for: Adults living with chronic fatigue, persistent post-viral fatigue, or overlap conditions where post-exertional malaise is a defining feature. Also relevant for fibromyalgia and related multi-system fatigue presentations.

How it works: A PEM-informed approach combining basic diagnostics, ALIV’s Fatigue Fighter IV drip for nutritional replenishment and oxidative stress reduction, mitochondrial rejuvenation with NAD+/NMN, sleep support where needed, gut and systemic inflammation work where needed, and — for individuals above 45 — autologous cell therapy as a stronger regenerative pathway.

What to expect: Recovery is non-linear, often partial, and slow. Many clients report meaningful gains in functional capacity, energy, sleep, and cognitive symptoms over months. ALIV does not guarantee recovery, remission, or return to pre-illness baseline.

Who This Protocol Is For

Chronic fatigue is a serious, multi-system illness — and one of the most medically marginalised conditions in India and worldwide. Patients are routinely told their symptoms are psychological, instructed to exercise more, or dismissed. The biology is real: research has identified consistent abnormalities in mitochondrial function, immune regulation, autonomic control, gut microbiome, and cellular energetics.

In India, chronic fatigue is more common than recognised. A foundational community survey in Goa of nearly 2,500 women aged 18-50 found 12.1% reported chronic fatigue lasting six months or longer — a syndrome rarely diagnosed formally in India. Long COVID has further expanded the population with persistent post-viral fatigue.

This protocol was built for you if:

• You’ve been diagnosed with chronic fatigue syndrome, post-viral fatigue, or fibromyalgia
• You experience post-exertional malaise — worsening symptoms 12-48 hours after even mild exertion, lasting days
• You’ve had persistent, unexplained, activity-limiting fatigue for six months or longer not relieved by rest
• You experience unrefreshing sleep, cognitive dysfunction, or orthostatic intolerance alongside fatigue
• Your illness started after a viral infection, surgery, major stress, or gradually without clear trigger
• You’ve been told your symptoms are “just stress” or “psychological” despite your clear sense otherwise
• You have overlap features — fibromyalgia, POTS, mast cell activation, persistent post-viral syndromes

Important: This protocol is integrative supportive care, not replacement for medical care. ALIV is not a tertiary chronic fatigue specialty centre. Where complications require specialist management (severe POTS, MCAS workup, dysautonomia testing), ALIV coordinates with specialists.

How It Works — The ALIV Approach

The single most important principle in chronic fatigue management: post-exertional malaise (PEM) is a defining feature, and the “exercise your way out” approach is actively harmful. Graded exercise therapy as traditionally applied is no longer recommended (NICE UK 2021). Every layer of this protocol respects PEM and operates within pacing principles.

Layer 1 — Diagnostics

Before any intervention, your ALIV physician runs a focused workup: inflammatory markers (hsCRP, ESR), ferritin, full thyroid panel, vitamin D, B12, magnesium, cortisol levels, and other basic blood work. The protocol is shaped by what this reveals.

Layer 2 — Fatigue Fighter IV Drip

ALIV’s Fatigue Fighter IV is the foundational intervention — nutritional replenishment combined with antioxidant support to reduce oxidative stress. Delivered intravenously to bypass impaired gut absorption common in chronic fatigue states, it provides immediate bioavailable support for clients whose baseline energy is too depleted to make oral protocols effective on their own.

Layer 3 — Mitochondrial Rejuvenation

Mitochondrial dysfunction is one of the most consistently documented abnormalities in chronic fatigue — impaired ATP production and what landmark metabolomic research described as a hypometabolic state. Targeted intervention with CoQ10/Ubiquinol, NAD+ precursors (NMN/NR), D-ribose, L-carnitine, magnesium, methylated B-complex addresses these abnormalities. ALIV’s NAD+ Vitality IV provides bioavailable cellular energy support. For individuals above 45 or with significant mitochondrial decline, SS-31 — a peptide that stabilises cardiolipin in the inner mitochondrial membrane — can be added to restore mitochondrial efficiency. Mitochondrial-derived peptides such as MOTS-c are also of interest, though not yet established standard of care.

Layer 4 — Sleep Support (Where Needed)

Unrefreshing sleep is one of the most disabling features. Where sleep is a significant issue, the protocol coordinates with the Sleep Protocol — sleep hygiene, magnesium glycinate, glycine, and targeted support. Where indicated, Epitalon (a pineal peptide supporting melatonin rhythm) or DSIP (delta sleep-inducing peptide) can be considered. Gains here often unlock progress in other layers.

Layer 5 — Gut and Systemic Inflammation (Where Needed)

Chronic fatigue often involves immune dysregulation and gut disturbance. Where these features dominate, the layer adds inflammatory marker tracking, gut work coordinated with the Gut Barrier Protocol, BPC-157 for gut lining repair, and — in recurrent post-viral patterns — Thymosin Alpha-1 as an immune modulator.

Layer 6 — Autologous Cell Therapy (Individuals 45+)

For individuals above 45 where the prior layers are insufficient, ALIV’s autologous cell therapy pathway provides a stronger regenerative anti-aging intervention. Investigational; reserved for selected clients after diagnostic workup and optimisation of the foundational layers. Evidence is early; outcomes not guaranteed.

What to Expect

Chronic fatigue recovery is genuinely different from most conditions ALIV treats. Not a six-month programme with a defined endpoint — it is long-term management. Outcomes vary enormously. ALIV does not guarantee recovery, remission, or return to pre-illness baseline.

The Lifestyle Layer — Non-Negotiable

In chronic fatigue more than any other ALIV protocol, what you do between appointments matters more than what happens in the clinic.

Pacing — The Single Most Important Concept

PEM responds to pacing, not pushing through. The cultural reflex — “you just need to be more active” — is exactly wrong here. Stay within your energy envelope. Use a heart rate monitor if helpful. Plan rest before and after exertion. The protocol fails without this.

Sleep, Nutrition, Autonomic Regulation, Infection Prevention

Sleep: non-negotiable; quality, consistency, and depth are protected. Nutrition: higher protein, careful micronutrient repletion (iron, B12, vitamin D, magnesium), anti-inflammatory patterns; small frequent meals if orthostatic. Autonomic regulation: slow breathing, gentle restorative practices, vagal work — within PEM limits. Infection prevention: each infection risks setback. Vaccination individualised; exposure reduction in high-risk windows is reasonable. Household: recovery is harder when family dismisses the illness. Family education is part of the protocol where helpful.

Frequently Asked Questions

Is chronic fatigue a real illness? I’ve been told it’s psychological.

Yes, real. Not psychological. Chronic fatigue syndrome has documented biological abnormalities including mitochondrial dysfunction, immune dysregulation, autonomic disturbance, and a distinct hypometabolic chemical signature. It is formally recognised internationally as a serious physical illness.

How is this different from the Post-COVID Recovery Protocol?

Significant overlap — long COVID and chronic fatigue share biology, and PEM is central to both. The Post-COVID / Long COVID Recovery Protocol is the right start if your illness clearly followed COVID. This protocol is for established chronic fatigue, non-COVID post-viral fatigue, or overlap presentations.

What about graded exercise therapy? My doctor recommended it.

Traditional graded exercise therapy is no longer recommended for chronic fatigue syndrome in updated guidelines (NICE UK 2021 explicitly advised against fixed-increment GET) because of PEM-induction risk. Carefully paced, symptom-titrated movement within the energy envelope is different and can be beneficial.

Is there a peptide that treats chronic fatigue?

No peptide is FDA-approved or standard of care for chronic fatigue syndrome. Some — Thymosin Alpha-1 in post-viral contexts, mitochondrial-derived peptides in early research — are biologically plausible candidates. ALIV uses these case-by-case as investigational adjuncts, never as primary therapy.

Can this help with fibromyalgia, POTS, or mast cell activation?

Yes — these conditions have significant overlap with chronic fatigue and often co-occur. The protocol is adapted based on dominant features. Specialist co-management is recommended for prominent POTS or MCAS.

Who should NOT do this protocol?

Severe chronic fatigue requiring inpatient or home-based care; active unstable medical conditions; clients seeking pushing-based recovery; those unable to commit to pacing principles.

Take the Next Step

Chronic fatigue is a serious illness the medical system has under-recognised for decades. The path forward is rarely a single intervention — it is a careful, biology-informed, pacing-respectful protocol delivered by clinicians who understand it.

To find out if the Chronic Fatigue Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. Patel V, Kirkwood BR, Weiss H, Pednekar S, Fernandes J, Pereira B, et al. Chronic fatigue in developing countries: population based survey of women in India. BMJ. 2005;330(7501):1190. PMID: 15870118

2. Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18(1):100. PMID: 32093722

3. Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113(37):E5472-E5480. PMID: 27573827

4. Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29(1):19-36. PMID: 24557875

5. NICE Guideline NG206. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. National Institute for Health and Care Excellence; 2021.

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including chronic fatigue syndrome, myalgic encephalomyelitis, fibromyalgia, POTS, mast cell activation syndrome, or any post-viral fatigue condition. This protocol is integrative supportive care provided alongside — not as a replacement for — specialist medical management where applicable. Outcomes vary substantially; ALIV does not guarantee recovery, remission, return to pre-illness baseline, or any specific clinical outcome. Chronic fatigue syndrome is a serious chronic illness that often requires long-term management. Peptide therapies used as regenerative adjuncts are investigational; no peptide is FDA-approved specifically for chronic fatigue syndrome. Pacing within personal energy limits is foundational — graded exercise therapy as historically applied is no longer recommended. Please consult a qualified healthcare professional before starting any therapy programme.